- Home
- PAMT vs CATX Comparison
PAMT vs CATX Comparison
Compare PAMT & CATX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PAMT
- CATX
- Stock Information
- Founded
- PAMT 1980
- CATX 1983
- Country
- PAMT United States
- CATX United States
- Employees
- PAMT N/A
- CATX N/A
- Industry
- PAMT Trucking Freight/Courier Services
- CATX Medical/Dental Instruments
- Sector
- PAMT Industrials
- CATX Health Care
- Exchange
- PAMT Nasdaq
- CATX Nasdaq
- Market Cap
- PAMT 258.2M
- CATX 239.0M
- IPO Year
- PAMT 1985
- CATX N/A
- Fundamental
- Price
- PAMT $11.06
- CATX $3.87
- Analyst Decision
- PAMT Hold
- CATX Strong Buy
- Analyst Count
- PAMT 1
- CATX 10
- Target Price
- PAMT $13.00
- CATX $12.90
- AVG Volume (30 Days)
- PAMT 9.8K
- CATX 835.6K
- Earning Date
- PAMT 10-23-2025
- CATX 11-11-2025
- Dividend Yield
- PAMT N/A
- CATX N/A
- EPS Growth
- PAMT N/A
- CATX N/A
- EPS
- PAMT N/A
- CATX N/A
- Revenue
- PAMT $655,581,000.00
- CATX $1,235,000.00
- Revenue This Year
- PAMT N/A
- CATX N/A
- Revenue Next Year
- PAMT $12.19
- CATX N/A
- P/E Ratio
- PAMT N/A
- CATX N/A
- Revenue Growth
- PAMT N/A
- CATX N/A
- 52 Week Low
- PAMT $10.71
- CATX $1.60
- 52 Week High
- PAMT $23.70
- CATX $13.44
- Technical
- Relative Strength Index (RSI)
- PAMT N/A
- CATX 53.74
- Support Level
- PAMT N/A
- CATX $3.37
- Resistance Level
- PAMT N/A
- CATX $3.78
- Average True Range (ATR)
- PAMT 0.00
- CATX 0.20
- MACD
- PAMT 0.00
- CATX 0.04
- Stochastic Oscillator
- PAMT 0.00
- CATX 66.14
About PAMT PAMT CORP Common Stock
PAMT Corp is a holding company that is engaged in providing truckload dry van carriers transporting general commodities throughout the continental United States, as well as the Canadian provinces of Ontario and Quebec. It has one reportable segment being motor carrier.
About CATX Perspective Therapeutics Inc.
Perspective Therapeutics Inc is a radiopharmaceutical development company that is pioneering advanced treatment applications for cancers throughout the body. The Company has a proprietary technology that utilizes the alpha-emitting isotope Lead-212 (212Pb) to deliver powerful radiation specifically to cancer cells via specialized targeting moieties.